HSBC Holdings
BNTX icon

HSBC Holdings’s BioNTech BNTX Stock Holding History

HSBC Holdings’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,000
Closed -$108K – 2936
2021
Q1 		$108K Buy
+1,000
New +$106K ﹤0.01% 2629

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HSBC Holdings's BNTX Position: Q1 2026 in Review

HSBC Holdings reduced its BioNTech (BNTX) stake by 60% in Q1 2026, selling an estimated $3.23M and leaving 20,834 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #1570.

HSBC Holdings first reported a position in BNTX in Q3 2020 and has held it in 13 quarters since. The position peaked at $4.97M in Q4 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • HSBC Holdings held 20,834 shares of BioNTech worth $1.84M as of Q1 2026.
  • HSBC Holdings sold 31,445 BioNTech shares in Q1 2026, an estimated $3.23M.
  • BioNTech made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1570 holding.
  • HSBC Holdings first reported a position in BioNTech in Q3 2020 and has held it in 13 quarters since.
  • HSBC Holdings's BioNTech position peaked at $4.97M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.